The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study of pembrolizumab with or without radiation in patients with recurrent or metastatic adenoid cystic carcinoma.
 
Jonathan Daniel Schoenfeld
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Debiopharm Group; Nanobiotix; Tilos Therapeutics
Research Funding - Bristol-Myers Squibb; Merck
 
Umair Mahmood
No Relationships to Disclose
 
Yu-Hui Chen
Employment - Constellation Pharmaceuticals (I); Flagship VL59 (I)
Stock and Other Ownership Interests - Constellation Pharmaceuticals (I)
 
Raymond H. Mak
Consulting or Advisory Role - AstraZeneca
 
Jochen H. Lorch
Consulting or Advisory Role - Bayer; Eisai
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Millennium (Inst); Novartis (Inst)
 
Glenn J. Hanna
Honoraria - Society for Immunotherapy of Cancer
Consulting or Advisory Role - Bristol-Myers Squibb; Regeneron
Research Funding - Bristol-Myers Squibb (Inst); EMD Serono (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Regeneron
 
Vishwajith Sridharan
Employment - Takeda
Consulting or Advisory Role - Volcano Capital
 
Andrew Bang
No Relationships to Disclose
 
Paul Martin Busse
No Relationships to Disclose
 
Henning Willers
No Relationships to Disclose
 
Harvey J. Mamon
Honoraria - UpToDate
 
Hyung-Jin Yoo
No Relationships to Disclose
 
Sara I. Pai
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; CUE Biopharma; Merck; Newlink Genetics/Pharmatech
Research Funding - Abbvie; AstraZeneca/MedImmune (Inst); CUE Biopharma; Merck (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca/MedImmune; Merck
 
Lori J. Wirth
Consulting or Advisory Role - Amgen; Ayala Pharmaceuticals; Blueprint Medicines; CUE Biopharma; Eisai; Loxo; Merck; Novartis
Other Relationship - Iovance Biotherapeutics
 
Robert I. Haddad
Employment - Dana-Farber Cancer Institute
Leadership - NCCN
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Celgene; Eisai; Genentech; Immunomic Therapeutics; Loxo; Merck; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Kura Oncology (Inst); Merck (Inst); Pfizer (Inst); VentiRx (Inst)
 
Nicole Grace Chau
Research Funding - GlaxoSmithKline; Merck (Inst); Pfizer (Inst)